By coating tiny gel beads with lung-derived stem cells and then allowing them to self-assemble into the shapes of the air sacs found in human lungs, researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have succeeded in creating three-dimensional lung “organoids.” The laboratory-grown lung-like tissue can be used to study diseases including idiopathic pulmonary fibrosis, which has traditionally been difficult to study using conventional methods.
“While we haven’t built a fully functional lung, we’ve been able to take lung cells and place them in the correct geometrical spacing and pattern to mimic a human lung,” said Dr. Brigitte Gomperts, an associate professor of pediatric hematology/oncology and the study’s lead author.
Idiopathic pulmonary fibrosis is a chronic lung disease characterized by scarring of the lungs. The scarring makes the lungs thick and stiff, which over time results in progressively worsening shortness of breath and lack of oxygen to the brain and vital organs. After diagnosis, most people with the disease live about three to five years. Though researchers do not know what causes idiopathic pulmonary fibrosis in all cases, for a small percentage of people it runs in their families. Additionally, cigarette smoking and exposure to certain types of dust can increase the risk of developing the disease.
To study the effect of genetic mutations or drugs on lung cells, researchers have previously relied on two-dimensional cultures of the cells. But when they take cells from people with idiopathic pulmonary fibrosis and grow them on these flat cultures, the cells appear healthy. “Scientists have really not been able to model lung scarring in a dish,” said Gomperts, who is a member of the UCLA Broad Stem Cell Research Center. The inability to model idiopathic pulmonary fibrosis in the laboratory makes it difficult to study the biology of the disease and design possible treatments.
Gomperts and her colleagues started with stem cells created using cells from adult lungs. They used those cells to coat sticky hydrogel beads, and then they partitioned these beads into small wells, each only 7 millimeters across. Inside each well, the lung cells grew around the beads, which linked them and formed an evenly distributed three-dimensional pattern. To show that these tiny organoids mimicked the structure of actual lungs, the researchers compared the lab-grown tissues with real sections of human lung.
“The technique is very simple,” said Dan Wilkinson, a graduate student in the department of materials science and engineering and the paper’s first author. “We can make thousands of reproducible pieces of tissue that resemble lung and contain patient-specific cells.”
Moreover, when Wilkinson and Gomperts added certain molecular factors to the 3-D cultures, the lungs developed scars similar to those seen in the lungs of people who have idiopathic pulmonary fibrosis, something that could not be accomplished using two-dimensional cultures of these cells.
Using the new lung organoids, researchers will be able to study the biological underpinnings of lung diseases including idiopathic pulmonary fibrosis, and also test possible treatments for the diseases. To study an individual’s disease, or what drugs might work best in their case, clinicians could collect cells from the person, turn them into stem cells, coax those stem cells to differentiate into lung cells, then use those cells in 3-D cultures. Because it’s so easy to create many tiny organoids at once, researchers could screen the effect of many drugs. “This is the basis for precision medicine and personalized treatments,” Gomperts said.
The Latest on: Precision medicine
via Google News
The Latest on: Precision medicine
- Precision Medicine Market SWOT Analysis by Size, Status and Forecast to 2020-2026: Illumina, Roche, Abbott Laboratorieson January 19, 2021 at 11:45 am
The Global Precision Medicine Market has witnessed continuous growth in the past few years and may grow further during the forecast period (2020-2026).
- How One Million Volunteers Could One Day Revolutionize Medicineon January 19, 2021 at 10:00 am
A bold NIH program promises groundbreaking insights into some of the nation’s deadliest diseases. Researchers want hundreds of thousands of volunteers to get involved.
- QIAGEN Adopts GNS Healthcare’s Gemini - The in silico Patient™ Across Multiple Cancerson January 19, 2021 at 8:51 am
PRNewswire/ -- GNS Healthcare, the leading AI-driven precision medicine company, today announced a partnership with QIAGEN, the leading global provider of Sample to Insight solutions for molecular ...
- Dr. Narla on Advances Made With Precision Medicine in Oncologyon January 18, 2021 at 4:17 pm
Goutham Narla, MD, PhD, discusses advances made with precision medicine in oncology. Goutham Narla, MD, PhD, an associate professor in the Department of Medicine; chief of the Division of Genetic ...
- Precision Medicine Market Size is Expected to Reach USD 141.33 Billion by 2027on January 18, 2021 at 2:28 am
The precision medicine market size was surpassed USD 59.16 billion in 2019 and expected to reach USD 141.33 billion by 2027 and growing at impressive CAGR of 11.5% during the forecast period 2020 to ...
- Gene Involved in Breast Cancer Growth May Speed Precision Medicineon January 14, 2021 at 10:22 am
Researchers have discovered that women with breast cancer have high levels of a specific gene, a finding that could lead to new precision medicine treatments for the disease.
- Precision Medicine Group Significantly Expands Cell And Gene Therapy Expertise With Acquisition Of Project Farmaon January 14, 2021 at 6:05 am
PRNewswire/ -- Precision Medicine Group ("PMG") announced today it has acquired Project Farma, a patient-focused bioengineering services firm that ...
- Diabetes research in era of precision medicine, Covidon January 12, 2021 at 1:26 pm
Diabetes is a major healthcare challenge and priority in Qatar, with its prevalence currently at 17% ? twice the global average. Ten percent of diabetes cases are type 1 (T1D) and 90% are type 2 (T2D) ...
- Precision Medicine Market- Competitive Scenario, Strategic Management, Massive Growth, and Developments in the Market, 2027on January 12, 2021 at 6:10 am
Recent report published by research nester titled "Precision Medicine Market: Global Demand Analysis & Opportunity Outlook 2027"delivers the detailed overview of the global precision medicine market ...
via Bing News